69 results
424B3
BXRXQ
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
basis, including cash equivalents, warrants, and contingent consideration. The Company’s assessment of the significance of a particular input … are permitted to exclude acquisitions from their assessment of internal control over financial reporting during the first year of an acquisition while
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
European Union member states are subsequently required to grant marketing authorization for their territory on the basis of this assessment, except … liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on the level of the historical taxable income
DEFA14A
EX-99.1
yjdc1b6w a5udz
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.1
oj9yb4m ir8c
9 Aug 23
Other Events
5:27pm
DEFA14A
sno81x2h amvrzbk8s4
5 Jul 23
Additional proxy soliciting materials
5:28pm
8-K
EX-2.1
kpbyhr1 62twng07j
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-99.1
tnbm9u sw
28 Jun 23
Other Events
4:31pm
8-K
EX-99.1
f9k8vacw4jlf9b2
10 May 23
Regulation FD Disclosure
8:01am
424B3
xtki3fubmii
28 Apr 23
Prospectus supplement
4:02pm
8-K
EX-99.1
dpw86
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
8-K/A
EX-10.3
l0tnjnl4
4 Apr 23
Entry into a Material Definitive Agreement
4:09pm
424B3
952 gc5be0g1mc7i2
5 Dec 22
Prospectus supplement
4:37pm